載入...
The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors
The baculovirus expression vector system (BEVS) platform has become an established manufacturing platform for the production of viral vaccines and gene therapy vectors. Nine BEVS‐derived products have been approved – four for human use (Cervarix®, Provenge®, Glybera® and Flublok®) and five for veter...
Na minha lista:
| 發表在: | Biotechnol J |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
WILEY‐VCH Verlag
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7159335/ https://ncbi.nlm.nih.gov/pubmed/25800821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/biot.201400438 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|